
-
2008
Company Description
Minatx is a therapeutics company uses gene activation mechanisms to discover new medical treatments.
Harnessing the innate mechanism of gene activation, MiNA Therapeutics’ platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver diseases. Our initial product candidate will achieve clinical proof of concept in 2017.
-
Manufacturer:
Science and Engineering -
Formed:
2008 -
Company Website:
-
Company E-mail:
-
Company Address:
United KingdomLondon -
CEO:
- Robert Habib
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits